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SUMMARY-Activated, nonimmune macrophages exerted pro-
found effects on the proliferation and viability of eukaryotic
target cells in vitro. Pronounced macrophage-mediated cyto-
stasis was exerted on every rapidly proliferating cell line ex-
amined, irrespective of transformation, species derivation, cell
type, or growth characteristics. However, the magnitude of
cytostasis effected differed markedly among the 40 cell lines
tested. There was no evident correlation between susceptibility
to cytostasis and degree of transformation. Transformed cell
lines with high and with low malignant attributes were affected
equally. A comparable pattern was discerned for cytocidal
effects of macrophages, in which the susceptibility of trans-
formed targets was independent of the degree of malignancy.-
J Natl Cancer Inst 56: 369-374, 1976.
Recent work (1-5) has shown that apart from the im-
portant function of mononuclear phagocytes in patho-
logic processes, the presentation of antigen to immuno-
competent cells, and resistance against intracellular
microorganisms, mononuclear phagocytes also exert pro-
found effects on eukaryotic cells. These in vitro studies
have yielded voluminous data indicating that activated,
nonimmune macrophages (AM) can affect target cells in
a variety of ways, and that they can discriminate between
normal and transformed cells and resting and replicating
cells. These destructive capabilities apparently involve
the metabolic state of a macrophage population, as well
as the proportion of effectors to targets. The findings thus
far indicated that the cytostatic effects on targets exerted
by AM are independent of target species (syngeneic, allo-
geneic, or xenogeneic), target cell type (epithelial or lym-
phoid), target growth characteristics (monolayer or sus-
Pension), or transformation (normal vs. neoplastic tissue)
(4-7). There is general agreement (1-4, 8-10) that inter-
action of AM with tumor targets results in an altered
morphology and decrease in the number of cells, attesting
to the Al\tI's capacity to kill tumor targets in vitro. How-
ever, further investigation on many cell lines derived
from normal and transformed tissue disclosed that macro-
phage cytocidal target cell effects are not invariably
correlated with the malignant attributes of cell lines
derived from transformed tissue.5, 6 The present work
further explores whether the macrophage-mediated cyto-
cidal effect is selective for tumors.
MATERIALS AND METHODS
Target cell lines.-Rat: Cells derived from normal rat
kidney (NRK) and rat kidney cells infected with B77
Rauscher murine leukemia virus (B77 = NRK) (11), a gift
from Dr. T. Graf, were grown in Eagle's minimum essen-
tial medium (MEM) (12) modified as follows: 280 mg
glutamine/liter, 100 mg calcium/liter, 1 g NaHCOs/liter,
2 g glucose/liter, and 1 mg biotin/liter, and supple-
mented with 100 U penicillin/ml, 50ft streptomycin/ml
(modified MEM), 10% fetal calf serum (FCS), and 10%
tryptose phosphate (Difco Laboratories, Detroit, Mich.).
DA rat tumors were those described in (4) or were newly
induced with polyoma virus, dimethylbenz[a]anthracene
(DMBA), or 3-methylcholanthrene (MCA). These tumor
cells were grown in modified MEM supplemented with
10% newborn calf serum (NCS). DA rat adult and
embryo fibroblasts were repeatedly newly established (6)
and grown in modified MEl\tI supplemented with 10%
FCS.
Mouse: The A9 cell (having little ability to grow pro-
gressively in vivo), its highly malignant counterpart
A9HT (high incidence of take) (13), and the hybrid cell
lines between these L-cell derivatives and malignant
mouse tumors, such as Ehrlich (spontaneous carcinoma),
SEWA (polyoma-induced sarcoma), MSWBS (MCA-in-
duced sarcoma), and YACIR (an immunoresistant deriva-
tive of the YAC tumor, a Moloney virus-induced lym-
phoma) (13, 14), provided by Dr. George Klein, were
grown in nonmodified Eagle's MEM. BALB/c3T3 cells
and BALB / c simian virus 40 (SV40)-transformed 3T3
cells, originally obtained from Dr. Stuart Aaronson, were
maintained in modified l\-fEM with 10% FCS. Suspension
cultures of the transplantable murine mast cell tumor
P-815 X2, obtained from Drs. R. Schindler and M.
Bertschmann, were grown as described in (15); the me-
dium was supplemented with 10% NCS instead of horse
serum.
Human: Three adherent cell lines derived from hu-
man mammary carcinomas were used: BT-20, supplied
by Dr. J. Fogh, was grown in modified MEM supple-
mented with 10% FCS; MPZ-2 and MPZ-4 were freshly
established from a biopsy of human breast cancer, pro-
vided by Dr. J. R. Riittner and grown in modified MEM
supplemented with 15% FCS. Two human melanoma
lines were used. SK-melanoma-l (MEL-I) cells, obtained
from Dr. K. T. Brunner, were grown in suspension in
modified MEM supplemented with 10% FCS. Melanoma
cells (RPMI 7932), provided by Dr. W. D. Terry, were
grown in adherent culture in modified MEM with 10%
FCS. SK-OS-5, derived from an osteogenic sarcoma and
supplied by Dr. J. Fogh, was grown in adherent culture
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in modified MEM with 10% FCS. The Burkitt's lym-
phoma cell line RAJI, obtained from Dr. G. Klein, was
grown in modified MEM supplemented with 10% FCS.
BEN, a tumor cell line producing carcinoembryonic anti-
gen, was supplied by Dr. Ch. Sauter and grown in ad-
herent culture in modified MEM with 10% FCS. Cell
lines were repeatedly checked for the possibility of myco-
plasma contamination, but none was found.
Origin, culture conditions, and properties of other cell
lines used were described in (6).
Macrophage monolayers were prepared as described in
(4, 6). Peptone-induced peritoneal cells from inbred DA
rats were seeded into plastic petri dishes. After 30 min-
utes at 37° C, the nonadhering cells were removed by
intensive washing. After this procedure, at least 96% of
the cells in the monolayer of approximately 2 X 1~ cells
showed the characteristics of macrophages. To these
macrophage monolayers, target cells (2 X 105/dish) were
immediately added and the cultures were maintained at
the appropriate temperature in a humid atmosphere of
5% CO2and 95% air.
Measurement of cytostasis.-Residual target cell pro-
liferation was· assessed after varying intervals of macro-
phage-target cell interaction by: I) exposure for 60 min-
utes at 37° C to I ,p.Ci 3H-methylthymidine (3H-TDR)/
dish (5,000 mCi/mmole; The Radiochemical Centre,
Amersham, Buckinghamshire, England), and processing as
described in (4, 6); or 2) by exposure for 8 hours at 37° C
to 0.1 ,p.Ci 1251-5-iodo-2'-deoxyuridine (125IUDR, sp act,
8-10 p,Ci/p.g; The Radiochemical Centre). After careful
washing, the cells were washed twice with 1.5% perchloric
acid and radioactivity was measured in an automatic
gamma counter (Tracerlab, Inc., Waltham, Mass.).
Assessment of target cell viability.-Two methods were
used to assess target cell viability. In experiments per-
formed to assess the capacity of target cells to reestablish
growth, 2 X 105 targets were cultured in the presence of
2x l~ AM (6). After 72 hours, the cells were harvested
by trypsinization, washed, counted, and diluted to a
concentration of 300/3.5 ml; aliquots of this volume were
also dispensed to 30-ml Falcon culture flasks. After 10
days' incubation in 5% CO2 at 37° C, we assessed target
cell proliferation by adding 1 p.Ci 3H-TDR for 60 min-
utes at 37° C and by processing the cells as described.
Lines derived from the A9 cell were easily distinguished
morphologically from AM. Thus the number of target
cells remaining in culture after a 72-hour interaction
with AM could be counted after trypsinization.
In other experiments, the release of 125IUDR from
prelabeled targets was a measure of macrophage-medi-
ated target cell damage. Subconfluent cultures of target
cells grown in 250-ml Falcon tissue culture flasks con-
taining 10 ml medium were pulsed for 8 hours with Ip.Ci
125IUDR/flask (O.Ip.Ci/ml) in the presence of 2'-fluoro-5-
deoxyuridine (FUDR) at a concentration of 10-5 M. The
FUDR, a known inhibitor of thymidylate synthetase, was
included to increase 125IUDR incorporation into DNA
(16), in place of 3H-TDR.
In many target cell lines, incubation with a combina-
tion of 125IUDR and FUDR in the concentrations and
time indicated resulted in adequate specific labeling with-
out marked signs of toxici ty; these particular cell lines
were used here. Following incubation with 125IUDR for
8 hours, the cells were washed twice with phosphate-
buffered saUne to remove unincorporated isotope. The
prelabeled cells (2 X 105/dish) were then added to macro-
phage monolayers and incubated for varying intervals,
after which the cells were removed by a pipette and then
centrifuged. Supernatants and cells were enumerated
separately in an automatic Tracerlab gamma counter.
Results are expressed as a percent of cytocidal capacity,
calculated as follows:
Experimental dpm-control dpm X 100,
total dpm
where dpm = disintegrations per minute.
RESULTS
Cytostatic Target Cell Effects Mediated by Macrophages
Following interaction for different intervals with 10
macrophages per target cell, the 3H-TDR incorporation,
a measure of residual target cell proliferative capacity,
was profoundly diminished in all of the target cell lines
examined (table I). However, there were considerable
differences in the susceptibility of different target cell
lines to macrophage-mediated cytostasis. Proliferation of
several cell lines (i.e., polyoma virus-induced syngeneic
rat tumor cells, xenogeneic mouse SV403T3, and espe-
cially P-815 mastocytoma cells) was blocked even in the
early phase of interaction and remained at a very low
rate as interaction proceeded. Other cell lines were initi-
ally more resistant to macrophage-mediated cytostasis but
were inhibited during the later phases of interaction; this
was seen with 3T3, RPMI 7932, BEN, BT-20, MPZ-2,
MPZ-4, SK-OS, and MEL-I cells. Proliferation of RAJI
and several other human lymphoblastoid cell lines was
often enhanced in the early phase of interaction with
macrophages, but was subsequently diminished as the
interaction proceeded. DMBA- and MCA-induced syn-
geneic rat tumor cells, although effectively inhibited in
the early phase, retained proliferative capacity during
continuous interaction with macrophages. Proliferation
of fibroblasts, derived from rat embryo (or adult) tissues
and exposed to macrophages during in vitro passages 4-7
and 24-30, was distinctly diminished in the early phase
but often remained unchanged or was even enhanced as
interaction proceeded; such reversed reaction to macro-
phages was observed especially with recently explanted
fibroblasts. Thus in all target cell lines examined, pro-
TABLE I.-Marked inhibition of proliferation of normal and neoplastic
target cells (2Xl0 5) in the presence of 2X106 DA rat macrophages
Residual 3H-TDR incorporation (% of
Target control) after macrophage interaction for"
18 hr 36 hr 48 hr
Fibroblasts :
Passages 4-7 _______ 52 (±48) 36 (±26) 37 (±24)
Passages 24-30 _____ 32 (±16) 29 (±11) 17 (±11)Polyoma_____________ 23 (±5) 16 (±7) 14 (±7)MCA________________ 28 (±11) 19 (±16) 24 (±6)DMBA______________ 35 (±17) 28 (±13) 30 (±23)3T3 _________________ 53 (±20) 12 (±7) 9 (±6)SV403T3_____________ 27 (±1O) 10 (±6) 7 (±4)P-815________________ 3 (±3) 6 (±4) 7 (±6)RAJL _______________ 123 (±42) 51 (±17) 36 (±14)CLA-4_______________ 91 (±28) 23 (±9) 31 (±24)MEL-l ______________ 83 (±32) 19 (±9) 16 (±9)
RPMI 7932__________ 60 (±22) 7 (±2) 6 (±3)BEN ________________ 53 (±29) 12 (±6) 13 (±6)SK-OS_______________ 50 (±13) 15 (±6) 20 (±6)BT-20_______________ 41 (±17) 9 (±5) 8 (±4)MPZ-2 ______________ 49 (±26) 17 (±8) 11 (±4)MPZ-4 ______________ 59 (±33) 17 (±5) 20 (±12)
II Values are means (±SD) of 10-20 experiments, each performed in triplicate.
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liferation was clearly inhibited when the proportion of
macrophages was in the majority, but the pattern of
inhibition varied markedly from one cell line to another.
Results similar to those with 3H-TDR were obtained
when targets, which interacted for varying intervals with
macrophages, were pulse labeled with 125IUDR.
15 21. 36 1.8 72 hours
TEXT-FIGURE I.-Decrease in number of neoplastic and normal target
cells (initially 2 X 105) during interaction with macrophages
(2X IOn). Target cell lines: D = DMB-induced DA rat tumor
cells; .0. = polyoma-induced DA rat tumor cells; O=mouse SV403T3
cells; 0 =mouse 3T3 fibroblasts; \7=CHO hamster fibroblasts.
Closed symbols arc targets alone; open symbols are targets in the
presence of AM.
53 (±9)
35 (±6)
22 (±9)
29 (±6)
Cloning efficacy a
NRK
B77
ts, 38° C
ts, 33° C
Target cell lines
a Percent of control as represented by the capacity for 3R-TDR Incorporation.
Values are means (±SD) of 10 determinations.
TABLE 3.-Differing effects by AM on capacity of normal and
transformed targets to reestablish growth
cells were equally affected, irrespective of whether or not
they were permissive.
Experiments, in which loss of capacity to reestablish
growth after prolonged culture with AM was taken as a
measure of macrophage-mediated cytocidal target cell
effects, revealed a significant cloning reduction in all
cell lines examined (table 3). However, cytocidal effects
were most pronounced in transformed cells, and no dif-
ference occurred between cells grown under permissive or
nonpermissive condi tions.
It was recently shown that the fusion of highly malig-
nant mouse cells with normal cells or cells of low malig-
nancy yields a hybrid with suppressed malignant char-
acteristics (14). Among such hybrids, the A9 series is
particularly interesting since hybrids with the slightly
malignant L-cell subline showed suppressed malignancy,
but partners of the highly malignant L-cell subline re-
tained undiminished malignancy (13). Thus it appeared
that a comparison between pairs of A9, A9HT, and the
various A9-tumor hybrids might give information rele-
vant to the present issue.
Accordingly, the macrophage effects on five paired lines
consisting of a slightly malignant (A9) and highly malig-
nant (A9HT) counterpart were assessed. The data in
text-figure 2 show that in every cell line examined, inter-
action with AM resulted in a marked diminution of
3H-TDR incorporation. However, when compared with
most previously examined cell lines, several L-cell hybrids
were surprisingly resistant to macrophage-mediated cyto-
stasis; this became especially evident after 4 and 15 hours.
After this interval, proliferation of a few cell lines was
even stimulated by AM. Again, the susceptibility of the
cell lines to macrophage-mediated cytostasis seemed inde-
pendent of the degree of malignancy.
When macrophage-mediated cytocidal effects. were as-
sessed by an enumeration of the targets remaining after
various intervals, all cell lines were comparably affected
(text-fig. 3). In the absence of effectors, the cell numbers
increased progressively; however, in their presence, cell
numbers remained low and decreased as interaction pro-
ceeded (table 4). Again, no clear distinction was found in
the susceptibility of cells with low or high malignancy
within each comparable pair.
•
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Cytostatic and Cytocidal Macrophage Effects on Targets of Low
and High Tumorigenicity
Enumeration of targets remaining after AM interac-
tion of some lines revealed that, irrespective of whether
targets were derived from normal or from transformed
tissues, their number decreased as interaction proceeded
(text-fig. 1). Since these experiments resolved neither the
issue whether macrophage cytostatic and cytocidal effects
were related nor whether cytocidal effects were indeed
tumor specific, further experiments were made on other
cell lines.
Cell lines derived from NKR, its virus-transformed
counterpart, and from a temperature-sensitive mutant
(ts 339) permissive at 33° C but not at 38° C (11), pro-
vided a useful model to probe the extent to which macro-
phage-mediated cytostatic and cytocidal effects are re-
lated to malignancy. Proliferation rate among these cells
differed considerably, but was high enough in each
instance to enable reliable quantitation of 3H-TDR in-
corporation into target cell DNA (table 2). These data
show that in everyone of these cell lines the residual
capacity to 3H-TDR decreased as the period of inter-
action with AM increased. Moreover, the findings showed
that NRK cells, although significantly inhibited, were
less susceptible to macrophage-mediated cytostasis than
were the transformed lines. However, the transformed
TABLE 2.-Correlation between degree of macrophage-mediated cytostasis and growth characteristics of different rat cell lines
Residua1 3H-TDR incorporation (% of control) by targets post culture with AM in ratio of
Target a Proliferative capacity 10 AM/target after interaction with AM for b
(dpm at 60 hI')
12 hI' 24 hI' 36 hI' 48 hI' 60 hI'4 hI'
NRK 16,000-26,000 82 (±2l) 50 (±15) 38 (±12) 30 (±8) 32 (±3) 32 (±5)
B 77 34,000-88,000 63 (±1O) 31 (±6) 14 (±3) 11 (±1 ) 11 (±3) 10 (±2)
ts, 38° C 48,000-120,000 52 (±9) 16 (±9) 8 (±2) 8 (±4) 8 (±4) 8 (±2)
ts, 33° C 82,000-212,000 40 (±19) 13 (±4) 8 (±5) 10 (±7) 5 (±3) 4 (±l)
a B1J =NRK cells infected with Bn avian sarcoma VIrus; Is =NRK cells infected with temperature-sensitive mutant Is 339. permissive at 33° C and reverted to a normal
phenotype at 38° C.
b Values represent means (±8D) of 10 determinations.
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TABLE 4.-Effect of AM on capacity of pairs of targets of low
and high tumorigenicity to reestablish growth
Tumorigenicity Number of targets a
Low:
A9___________________________________ 14
A9IMSWBS _ _________________________ 4
A9 ISEWA. ___________________________ 2
A9/EA_ ______________________________ 14
A9IYACIR . ________ 7
High:
A9HT________________________________ 13
A9HTIMSWBS_ ______________________ 12
A9HTISEW A_ ________________________ 9
A9HTIEA_ ___________________________ 11
A9HTIYACIR ________________________ 1
a Absolute No. of targets (Xl()4; initially 2 XlOo) remaining in culture after 96-hr
interaction with AM.
tumor cells, retained a high proportion of the label for
at least 48 hours, whereas others (especially MEL-I, BEN,
BT-20, and rat fibroblasts) often showed considerable
spontaneous release. This leakage is probably an expres-
sion of 125IUDR- and/or FUDR-mediated toxicity. Al-
though these differences in resistance to the labeling
procedure may considerably affect the outcome of cyto-
cidal tests, the measurements of the label release from
target cells proved reproducible and provided informa-
tion. The results in table 5 show that macrophage-
mediated release of 125IUDR from prelabeled target cells
was consistently observed after 18 hours; after an 8-hour
interaction, no such release was detectable. In many cell
lines, and most evident in those with low spontaneous
release (RPMI 7932, SK-OS, and RAJI), specific release
increased as interaction proceeded. However, other cell
lines including P-8I5, MEL-I, 3T3, SV403T3, BT-20,
BEN, MPZ-2, MPZ-4, and CLA-4, were also susceptible
to cytocidal macrophage effects. No difference was dis-
cerned between "normal" 3T3 fibroblasts and their virus-
transformed counterparts. Among the cells examined,
recently explanted syngeneic rat fibroblasts and D:MBA-
induced syngeneic rat tumors were resistant; cytocidal
effects were not consistently detectable.
A comparison of cytostatic and cytocidal macrophage
effects on these targets (tables 1, 5) indicates that the
TABLE 5.-Susceptibility of various target cell lines to
macrophage-mediated cytocidal effects
Cell line
Percent of cytocidal activity effected
(12bIUDR release) at a
18 hr 36 hr 48 hr
Fibroblasts
Passages 4-7 _______ 15 (±14) 9 (±7) 8 (±7)
Passages 24-30 _____ 17 (±8) 19 (±12) 21 (±!))
Polyoma_____________ 5 (±S) ~) (±6) 21 (±1O)
MCA________________ 14 (±16) 12 (±9) U (±8)
DMBA______________ 9 (±5) 9 (±6) 8 (±15)3T3 _________________ 13 (±5) 9 (±9) 10 (±8)
SV403T3 ____________ 16 (±4) 23 (±5) 16 (±5)P-815 _______________ 20 (±5) 28 (±1O) 28 (±4)
RAJI _______________ . 3 (±3) 30 (±7) 37 (±7)
CLA-4_______________ 6 (±4) 17 (±~)) 18 (±7)
M EL-l ______________ 23 (±8) 38 (±6) 45 (±5)
RPMI7932 __________ 11 (±4) 44 (±1O) 50 (±7)BEN ________________ 3 (±3) 10 (±1O) 13 (±17)
SK-OS ______________ 23 (±4) 48 (±1O) 48 (±7)BT-20 _______________ 20 (±6) 49 (±17) 59 (±6)
MPZ-2 ______________ 30 (±11) 28 (±11) 26 (±6)
MPZ-4 ______________ 9 (±6) 12 (±7) 12 (±6)
"Values are means (±SD) of 10-15 experiments, each performed in trivlicatc
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TEXT-FIGURE 2.-Macrophage-mediated (2 X 106) inhibition of target
cell (2 X 105) proliferation is not dependent on degree of tumori-
genicity. Target cell lines: .=A9; O=A9HT; .=A9/SEWA;
\7=A9HT/SEWA; .=A9/MSWBS; O=A9HT/MSWBS; .=A9/
YACIR; L.:,.=A9HT/YACIR; +=A9/EA; <:>=A9HT/EA. Closed
symbols are slightly malignant derivatives; open symbols are
highly malignant derivatives.
24 6 holrs
TEXT-FIGURE 3.-ln pairs of L-cell derivatives with low (A9) and
high (A9HT) tumorigenicity, the number of targets (initially
2 X 105) was similarly affected during interaction with 2 X 106 DA
rat macrophages. Target cell lines: 0 = A9; \7 = A9 / SEWA;
O=A9/MSWBS; L.:,.=A9/YACIR; <:>=A9/EA; ¢=A9HT; y=A9HT/
SEWA; ijJ=A9HT/MSWBS; ,6.=A9HT/YACIR; t=A9HT/EA.
Open symbols are targets alone; closed symbols are targets in the
presence of AM.
Cytocidal Effects Mediated by Macrophages
Among the cell lines suitable for cytocidal experiments
(i.e., those which incorporated and subsequently retained
an appropriate amount of 125IUDR), considerable differ-
ences were seen in label retention. Some cell lines, e.g.,
RAJI, RPMI 7932, SK-OS, or polyoma virus-induced rat
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changes in these parameters during interaction were not
consistently parallel. A close parallelism in the degree and
time course of cytostatic and cytocidal manifestations
was especially notable in the Iymphoblastoid lines RAJI
and CLA-4 and in rat fibroblasts. However, no such
parallelism in cytostatic and cytocidal effects was seen in
polyoma virus-induced DA rat tumor and P-815 mouse
mastocytoma cells.
DISCUSSION
Prior in vitro studies (4, 6) in this laboratory con-
si~tently demonstrated that interaction of macrophages
WIth targets first affects target cell proliferation and is
often accompanied by a decrease in the number of tar-
gets; the capability of remaining targets to reestablish
growth was diminished. These studies led to the provi-
sional conclusion that macrophage-mediated cytostasis
transcends species, cell type, and growth characteristics
and is exerted on all rapidly replicating cells, whether
derived from normal or transformed tissues (4-7). The
data reported here encompass more target cell lines and
show that prolonged interaction with a majority of mac-
rophages (effector to target cell ratio is 10: I) results in
a distinct inhibition of target cell proliferation in every
cell line examined, but the degree of cytostasis evoked by
macrophages differs markedly from one cell line to an-
other. The results were similar irrespective of whether
3H-TDR or 125IUDR was used as a pulse label to assess
the residual proliferative capacity. Since macrophages do
not replicate under tissue culture conditions and remain
in the G1 or Gil phase of the cell cyde, incorporation of
these labels is sharply restricted to target cells.
The data once again demonstrate that there are major
differences in the susceptibility of cell lines. When a
large array of cell lines is ranked by their susceptibility
to macrophage-mediated cytostasis, normal replicating
lymphoid cells (7), various virus-transformed lines (rat
polyoma and B77 , mouse SV40), P-815 mouse mastocytoma
cells, and some cell lines derived from human malignant
tumors are especially sensitive; derivatives of the mouse
~ fibro~last, t?ough consistently blocked after prolonged
InteractIOn WIth macrophages, showed large differences
in their initial sensitivity not correlated with their degree
of malignancy. Other lines such as 3T3, CHO, DMBA-
and ~1CA-induced rat tumor cells, the lymphoblastoid
cell hnes, and recently explanted fibroblasts derived from
normal adult or embryonic DA rat tissue, were resistant
to macrophage-mediated cytostasis. Accordingly, it is
evident that in rapidly replicating cell lines, factors other
than capacity for in vivo malignancy or in vitro trans-
formation determine susceptibility to macrophage-
mediated cytostasis.
Earlier studies (4) showed that indicators of immune
cytotoxicity such as those widely employed in lymphocyte-
target studies (i.e., release of 51Cr or uptake of trypan
?lue) were unsuitable for detection of macrophage-
Induced ch~nges in target cell viability. Accordingly, in
some expenments, the number of target cells remaining
after various intervals of interaction with macrophages
was counted for quantitation of cytocidal macrophage
effects on targets; the number of remaining targets shows
some diminution by 24 hours and is further decreased as
the i~te!action proceeds. However, many targets often
remaIn In culture even after a 96-hour interaction with
macrophages (table 4).
125IUDR has been used more frequently as a label of
target cells for the detection of lymphocyte-mediated
cytotoxicity (17-21). The main advantages of '125IUDR
a.re low spo~taneous release and little, if any, reutiliza-
tlon. Ac~or~Ingly, release of the isotope from prelabeled
targets lI~dIcates cell death and lysis (22-25); since
125IUDR IS. a gamma-emitting isotope, little preparation
?f sa~ples IS needed before counting. However, 125IUDR
IS toxIC (26, 27) a~d often blocks further cell replication.
The pre~ent studIes show, however, that despite consid-
erabl~ dIfferences amonp- the various cell lines, toxici ty
contnbuted by the labelIng procedure can be held within
acceptable limits, provided the isotope concentration is
kept low and incubation is limited to 8 hours. Under
such ~onditio~s, the incl~sion of FUDR to increase pref-
erentIally th~ IncorporatIOn of IUDR into DNA in place
of 3H-TDR IS a necessary precondition. vVith the use of
these mo~ifications, target cell lines were sufficiently
labeled WIthout pross signs of toxicity; i.e., 125IUDR-
labeled cells rephcated at a rate similar to that of un-
labeled controls. Thus the present work shows that this
method of meas~ring cytocidal (and cytostatic) capacities
of effectors applIes to targets long established in culture
or ~ecently de.rived from n.ormal tissues, growing adherent
or In suspenSIOn, or shOWIng growth attributes typical of
normal or transformed cells.
The accu~ate me.asu~ement of viability in a variety of
targets an~ Its applIcatlon. to macrophage-mediated effects
are essent~al for furthenng the understanding of the
processes Involved in the interaction between macro-
phages and oth~r euka~yote cells. Our work clearly dem-
o~strates t?at InteractIOn of nonimmune macrophages
WIth. a vanety of prelabeled targets is accompanied by a
conSIstent release of the label. Such release is not usually
detectable before 18 hours, but often increases as inter-
action .proceeds. Beyond the principal demonstration of
t?e eXIstenc~ of the potent cytocidal or cytolytic capaci-
tles of n?l1l~~une macrophages, the present findings,
though stl.ll l~mlted,. a~e informative in many ways. Thus
the ~ata I~dIcat~ dIstInct. ~i~erences among the targets
exam~ned In theIr susceptIbIlIty to macrophage-mediated
cytoCIdal effects. For example, carcinogen-induced tumor
cells and recent explants of normal fibroblasts, both of
syngeneic origin, seem particularly resistant.
O~ the basis of morphologic grading of macrophage-
me~~hated target. cell cytotoxicity, neoplastic cells are
unIquely susceptIble as contrasted to their normal coun-
terparts (3, 4~ 10). How~ver, both previous (6,28,29) and
present findIngs shOWIng that transformed cells are
affected ~q~ally whether they are grown at permissive or
~onpermI~sIve t~mper~tures, or whether they differ con-
sidera~ly III theIr .malIgnant potential, now indicate that
the pnor .concluSIOI1S were overgeneralized. These data
and espec~ally those ab~:)Ut. recent explants of rat fibro-
blasts IndIcate a quantItatIve rather than a qualitative
difference in susceptibility of normal and transformed
targets to macrophage-mediated cytocidal effects. Further
studies with cells recently derived from normal tissues
~especially primary explants) are necessary to clarify this
Issue.
I~ many tar~et cell lines, macrophage-mediated cyto-
statIC and cytoCIdal effects showed considerable parallel-
ism. For example, recent explants of DA rat fibroblasts
and carcinogen-induced DA rat cell lines, as well as
human Iymphoblastoid lines, were relatively resistant to
both effects. However, in polyoma-induced rat and P-815
~ouse cells, no such parallelism was observed; these cell
hnes, were hi~hly suscepti~le to cytostatic macrophage
e~ects but reSIstant to cytoCIdal macrophage effects. This
dIscrepancy suggests that cytostatic and cytocidal effects
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are not necessarily closely related. Earlier works (5, 7,30)
have convincingly shown that the effects on cell prolifera-
tion, both enhancing and blocking, are mediated by solu-
ble factors released from macrophages in in vitro culture.
However, close contact with targets seems necessary for
cytocidal and/or cytolytic effects of macrophages (31).
Most of the present comparative studies have been per-
formed in parallel with the same macrophage populations
for all targets. This is important since comparisons of
results of series of experiments have repeatedly disclosed
large quantitative differences (6, 7). Such differences as
previously observed in macrophage cytostatic activity
were probably sometimes due to differing degrees of
macrophage functional activities. Similarly, the present
variability in cytostatic (table 1) and cytocidal (table 5)
macrophage-mediated effects is mainly due to variations
in activity manifested by macrophages harvested from
different groups of inbred DA rats. Other variables, e.g.,
target cell characteristics, did not significantly affect the
outcome of the interaction. The quantitative differences
encountered in the degree of macrophage-mediated cyto-
stasis and cytolysis did not prejudice the principal con-
clusions discussed earlier.
Interpretation of the present findings is further com-
plicated by the likelihood that most of the lines generally
utilized as representative of "normal" cells, such as 3T3
or eRO cells, are not the unaltered host cells we seek.
In this respect, recent findings demonstrating that inocu-
lation of the "normal" BALB/ c3T3 cell line attached to
glass beads leads to malignant hemangioendotheliomas,
are significant (32). Thus we have reasons for believing
that the currently accepted view that postconfluence in-
hibition of cell division, low saturation density, and an-
chorage dependence are in vitro properties characteristic
only of normal nonmalignant cells, should now be reas-
sessed. These developments imply that eukaryotic cells
once established as cell lines (i.e., no longer under host
regulatory control) have the potential for malignancy.
Accordingly, the findings obtained with established cell
lines in vitro are not the direct and extrapolatable infor-
mation as previously viewed.
Despite these ambiguities, one salient point does
emerge. Among a larger number of transformed cell lines
with considerably differing malignant potential, there is
no ,correlation between the degree of transformation and
the susceptibility to macrophage cytocidal effects.
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